Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (51-60 of 271) with videos related to

Pageof 28
Sort By:
Science Translational Medicine|September 21, 2018
The hallmarks of successful anticancer immunotherapyLorenzo Galluzzi, Timothy A Chan, Guido Kroemer, et al.
Oncotarget|June 25, 2019
Immunomodulatory and immunotherapeutic implications of tobacco smoking in squamous cell carcinomas and normal airway epitheliumJingming Wang, Maximilian Linxweiler, Wei Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutationTimothy A Chan, Zhenghe Wang, Long H Dang, et al.
International Immunology|April 7, 2016
The role of neoantigens in response to immune checkpoint blockadeNadeem Riaz, Luc Morris, Jonathan J Havel, et al.
Human Vaccines & Immunotherapeutics|July 31, 2019
Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapyMark Lee, Robert M Samstein, Cristina Valero, et al.
NPJ Precision Oncology|April 8, 2022
Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockadeSeong-Keun Yoo, Diego Chowell, Cristina Valero, et al.
JAMA Network Open|February 28, 2022
Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint BlockadeSeong-Keun Yoo, Diego Chowell, Cristina Valero, et al.
Journal of Neuro-Oncology|September 18, 2012
Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional statusMarsha Reyngold, Andrew B Lassman, Timothy A Chan, et al.
Neoplasia (New York, N.Y.)|December 31, 2016
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of ApoptosisYongxing Gong, Steven E Schumacher, Wei H Wu, et al.
Acta Neurochirurgica|December 2, 2011
Radiation necrosis following treatment of high grade glioma--a review of the literature and current understandingAlan Siu, Joshua J Wind, J Bryan Iorgulescu, et al.
Pageof 28

Showing results (51-60 of 271) with videos related to

Sort By:
Pageof 28
Science Translational Medicine|September 21, 2018
The hallmarks of successful anticancer immunotherapyLorenzo Galluzzi, Timothy A Chan, Guido Kroemer, et al.
Oncotarget|June 25, 2019
Immunomodulatory and immunotherapeutic implications of tobacco smoking in squamous cell carcinomas and normal airway epitheliumJingming Wang, Maximilian Linxweiler, Wei Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutationTimothy A Chan, Zhenghe Wang, Long H Dang, et al.
International Immunology|April 7, 2016
The role of neoantigens in response to immune checkpoint blockadeNadeem Riaz, Luc Morris, Jonathan J Havel, et al.
Human Vaccines & Immunotherapeutics|July 31, 2019
Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapyMark Lee, Robert M Samstein, Cristina Valero, et al.
NPJ Precision Oncology|April 8, 2022
Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockadeSeong-Keun Yoo, Diego Chowell, Cristina Valero, et al.
JAMA Network Open|February 28, 2022
Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint BlockadeSeong-Keun Yoo, Diego Chowell, Cristina Valero, et al.
Journal of Neuro-Oncology|September 18, 2012
Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional statusMarsha Reyngold, Andrew B Lassman, Timothy A Chan, et al.
Neoplasia (New York, N.Y.)|December 31, 2016
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of ApoptosisYongxing Gong, Steven E Schumacher, Wei H Wu, et al.
Acta Neurochirurgica|December 2, 2011
Radiation necrosis following treatment of high grade glioma--a review of the literature and current understandingAlan Siu, Joshua J Wind, J Bryan Iorgulescu, et al.
Pageof 28